Resiquimod

TargetMol
Product Code: TAR-T6964
Supplier: TargetMol
CodeSizePrice
TAR-T6964-10mg10mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6964-25mg25mg£142.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6964-50mg50mg£185.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6964-100mg100mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6964-200mg200mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Resiquimod is an imidazoquinoline amine and Toll-like receptor (TLR) agonist with potential immune response modifying activity. Resiquimod exerts its effect through the TLR signaling pathway by binding to and activating TLR7 and 8 mainly on dendritic cells, macrophages, and B-lymphocytes. This induces the nuclear translocation of the transcription activator NF-kB as well as activation of other transcription factors. This may lead to an increase in mRNA levels and subsequent production of cytokines, especially interferon-alpha (INF-a) and other cytokines, thereby enhancing T-helper 1 (Th1) immune responses. In addition, topical application of resiquimod appears to activate Langerhans' cells, leading to an enhanced activation of T-lymphocytes.
CAS:
144875-48-9
Formula:
C17H22N4O2
Molecular Weight:
314.389
Pathway:
Proteases/Proteasome; Microbiology/Virology; Immunology/Inflammation
Purity:
0.9992
SMILES:
CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O
Target:
HCV Protease; TLR

References

Lee M, et al. Arch Pharm Res. 2014, 37(9), 1234-1240. Lor? K, et al. J Immunol. 2003, 171(8), 4320-4328. Gao Y, Wang K, Wang P, et al. A novel network pharmacology strategy to decode mechanism of Lang Chuang Wan in treating systemic lupus erythematosus[J]. Frontiers in Pharmacology . 2020, 11. Hemmi H, et al. Nat Immunol. 2002, 3(2), 196-200. Nadeem A, et al. Int J Biochem Cell Biol. 2016, 73, 53-62. Gao Y, Wang K, Wang P, et al A novel network pharmacology strategy to decode mechanism of Lang Chuang Wan in treating systemic lupus erythematosus. Frontiers in Pharmacology. 2020, 11. Zhou ZX, et al. Immune effects of R848: evidences that suggest an essential role of TLR7/8-induced, Myd88- and NF-?B-dependent signaling in the antiviral immunity of Japanese flounder (Paralichthys olivaceus). Dev Comp Immunol. 2015 Mar;49(1):113-20.